Group One Trading
HRMY icon

Group One Trading’s Harmony Biosciences HRMY Stock Holding History

Group One Trading’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-123,100
Closed -$3.45M – 7977
2026
Q1 		$3.45M Buy
123,100
+106,100
+624% +$3.48M 0.01% 1590
2025
Q4 		$636K Sell
17,000
-7,800
-31% -$256K ﹤0.01% 3277
2025
Q3 		$683K Buy
24,800
+9,800
+65% +$338K ﹤0.01% 3390
2025
Q2 		$474K Sell
15,000
-200
-1% -$6.43K ﹤0.01% 3478
2025
Q1 		$504K Buy
+15,200
New +$545K ﹤0.01% 3076
2024
Q2 		– Sell
-4,100
Closed -$138K – 7050
2024
Q1 		$138K Sell
4,100
-4,000
-49% -$128K ﹤0.01% 3865
2023
Q4 		$262K Buy
8,100
+8,000
+8,000% +$223K ﹤0.01% 3620
2023
Q3 		$3.28K Sell
100
-30,500
-100% -$1.06M ﹤0.01% 6880
2023
Q2 		$1.08M Buy
30,600
+30,500
+30,500% +$1.05M ﹤0.01% 2295
2023
Q1 		$3.27K Buy
+100
New +$4.55K ﹤0.01% 6466

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Group One Trading's HRMY Position: Q2 2026 in Review

Group One Trading opened a new position in Harmony Biosciences (HRMY) in Q2 2026: 618 shares worth $22.5K. The stake represents ﹤0.01% of the portfolio and ranks #5934 among its holdings. This is a return to the name: Group One Trading previously reported a position in HRMY as recently as Q3 2024.

Group One Trading first reported a position in HRMY in Q1 2023 and has held it in 3 quarters since. The position peaked at $134K in Q1 2023. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Group One Trading held 618 shares of Harmony Biosciences worth $22.5K as of Q2 2026.
  • Harmony Biosciences was a new Group One Trading position in Q2 2026.
  • Harmony Biosciences made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #5934 holding.
  • Group One Trading first reported a position in Harmony Biosciences in Q1 2023 and has held it in 3 quarters since.
  • Group One Trading's Harmony Biosciences position peaked at $134K in Q1 2023.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.